Strober, B. ., Imafuku, S. ., Paul, C., Gooderham, M., Spelman, L., Seo, S. J., Passeron, T., Hoyt, K., Colombo, M. J., Banerjee, S., Augustin, M., Stein Gold, L., Alexis, A. F., Thaci, D., Lebwohl, M., Issa, N. T., & Cameron, M. C. (2024). Deucravacitinib in Plaque Psoriasis: Maintenance of Response Over 4 Years in the Phase 3 POETYK PSO-1, PSO-2, and LTE Trials. SKIN The Journal of Cutaneous Medicine, 8(4), s407. https://doi.org/10.25251/skin.8.supp.407